Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03573596
Title Persistence of MR3 in Chronic Myeloid Leukemia (CML) After a 2nd Stop of TKI Treatment (DASTOP2)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors VU University Medical Center
Indications

chronic myeloid leukemia

Therapies

Dasatinib

Age Groups: adult
Covered Countries FRA | DEU

Facility Status City State Zip Country Details
Aarhus University Hospital Recruiting Aarhus Denmark Details
Odense University Hospital Recruiting Odense Denmark Details
Helsinki University Hospital Recruiting Helsinki Finland Details
Centre Hospitalo-Universitaire Not yet recruiting Créteil France Details
University Hospital Recruiting Bonn Germany Details
VU University medical center Not yet recruiting Amsterdam 1081HV Netherlands Details
Albert Schweitzer Hospital Not yet recruiting Dordrecht Netherlands Details
Radboud University medical center Not yet recruiting Nijmegen Netherlands Details
Erasmus University medical center Not yet recruiting Rotterdam Netherlands Details
Haukeland, Bergen University Hospital Recruiting Bergen Norway Details
Oslo University Hospital Recruiting Oslo Norway Details
Stavanger University Hospital Recruiting Stavanger Norway Details
Tromsø University Hospital Recruiting Tromsø Norway Details
St Olavs Hospital-Trondheim University Hospital Recruiting Trondheim Norway Details
University Hospital Recruiting Linköping Sweden Details
Sunderby Sjukhus Recruiting Luleå Sweden Details
Lund University Hospital Recruiting Lund Sweden Details
Karolinska Hospital Recruiting Stockholm Sweden Details
Umeå University Hospital Recruiting Umeå Sweden Details
Uppsala University Hospital (Akademiska) Recruiting Uppsala Sweden Details
Örebro University Hospital Recruiting Örebro Sweden Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field